Evidence map›Paper›PMID 37987760›Full record

ArticleBlood advances2023

Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia.

Jerome Tamburini, Sarah Mouche, Clement Larrue, Nicolas Duployez, Audrey Bidet, Auriane Salotti, Pierre Hirsch, Lucie Rigolot, Sylvain Carras, Marie Templé and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jerome TamburiniTranslational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva and Swiss Cancer Center Leman, Geneva, Switzerland.ORCID 0000-0002-0167-5996
Sarah MoucheTranslational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva and Swiss Cancer Center Leman, Geneva, Switzerland.ORCID 0000-0002-2348-1746
Clement LarrueTranslational Research Centre in Onco-Hematology, Faculty of Medicine, University of Geneva and Swiss Cancer Center Leman, Geneva, Switzerland.
Nicolas DuployezLaboratory of Hematology, Centre Hospitalier Universitaire Lille, Lille, France.ORCID 0000-0002-3927-1022
Audrey BidetDepartment of Hematology Biology, Molecular Hematology, Bordeaux University Hospital, Haut-Levêque Hospital, Pessac, France.
Auriane SalottiHospices Civils de Lyon, Hôpital Lyon Sud, Service d'Hématologie Biologique, Lyon, France.
Pierre HirschCentre de Recherche Saint Antoine (CRSA), Assistance Publique Hôpitaux de Paris (AP-HP), Sites de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine University and Society (CURAMUS), Hôpital Saint-Antoine, Service d'Hématologie Biologique, Paris, France.
Lucie RigolotHematology Laboratory, CHU Toulouse, INSERM 1037, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.ORCID 0009-0001-1275-5422
Sylvain CarrasHematology Molecular Biology Department, Grenoble Alpes University, Institute for Advanced Biosciences (INSERM U1209, CNRS UMR 5309), University Hospital, , Grenoble, France.ORCID 0000-0002-0796-7914
Marie TempléUniversité Paris-Cité, Institut Cochin, Centre National de la Recherche Scientifique (CNRS) U8104, INSERM U1016, Paris, France.
Fabrizia FavaleCentre de Recherche Saint Antoine (CRSA), Assistance Publique Hôpitaux de Paris (AP-HP), Sites de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine University and Society (CURAMUS), Hôpital Saint-Antoine, Service d'Hématologie Biologique, Paris, France.
Pascale Flandrin-GrestaHematology Laboratory, University Hospital, Saint-Etienne, France.
Yannick Le BrisHematology Biology, Nantes Université, Centre Hospitalier Universitaire de Nantes, INSERM, CNRS, Université d'Angers, CRCI2NA, Nantes, France.ORCID 0000-0002-0095-6999
Anne-Sophie AlaryDepartment of Oncogenetics, Paoli-Calmette Institute, Marseille, France.
Laurent MauvieuxLaboratoire d'Hématologie, CHRU Strasbourg, INSERM U1113, Strasbourg, France.ORCID 0000-0002-9043-1845
Sylvie TondeurHematology Molecular Biology Department, Grenoble Alpes University, Institute for Advanced Biosciences (INSERM U1209, CNRS UMR 5309), University Hospital, , Grenoble, France.
Eric DelabesseHematology Laboratory, CHU Toulouse, INSERM 1037, Centre National de la Recherche Scientifique, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, Toulouse, France.ORCID 0000-0002-0928-0753
François DelhommeauCentre de Recherche Saint Antoine (CRSA), Assistance Publique Hôpitaux de Paris (AP-HP), Sites de Recherche Intégrée sur le Cancer (SIRIC) Cancer United Research Associating Medicine University and Society (CURAMUS), Hôpital Saint-Antoine, Service d'Hématologie Biologique, Paris, France.
Pierre SujobertHospices Civils de Lyon, Hôpital Lyon Sud, Service d'Hématologie Biologique, Lyon, France.
Olivier KosmiderUniversité Paris-Cité, Institut Cochin, Centre National de la Recherche Scientifique (CNRS) U8104, INSERM U1016, Paris, France.ORCID 0000-0002-6021-4057

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, Acutefms-Like Tyrosine Kinase 3HumansMutationFLT3 protein, humanfms-Like Tyrosine Kinase 3

Identifiers

PMID37987760
PMCPMC10733105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.